Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials. (2022)

First Author: Mossop H
Attributed to:  Development of a 'humanised' model for renal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.80591

Publication URI: https://www.repository.cam.ac.uk/handle/1810/333168

Type: Journal Article/Review